MGP Ingredients Schedules First Quarter 2018 Conference Call/Webcast for Wednesday, May 2
Apr 18, 2018 12:30 pm UTC| Business
ATCHISON, Kan., April 18, 2018 -- MGP Ingredients, Inc. (Nasdaq:MGPI), a leading supplier of premium distilled spirits and specialty wheat proteins and starches, today announced that it will hold a conference call and...
NetworkNewsWire Announces Publication on Lithium Exploration Ramping Up to Meet Demand
Apr 18, 2018 12:30 pm UTC| Business
NEW YORK, April 18, 2018 -- via NetworkWire – NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring QMC Quantum Minerals Corp....
Apr 18, 2018 12:30 pm UTC| Business
NEW YORK, April 18, 2018 -- via CannabisNewsWire -- CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Global Payout, Inc. (GOHE), a...
Capstone Turbine Reports Select Preliminary Q4 Fiscal 2018 Financial Results
Apr 18, 2018 12:30 pm UTC| Business
Capstone Sees a Strong Rise in New Product Orders with a 1.3:1 Book-to-Bill Ratio A Return to Annual Revenue Growth with a Year-over-Year Increase of Approximately 7% Cash Usage Declines 44% for Fiscal 2018 Compared to...
Accelerize Inc. to Attend SunTrust Robinson Humphrey Internet & Digital Media Conference
Apr 18, 2018 12:30 pm UTC| Business
San Francisco Event Draws Investors and Industry Leaders from Private and Public Companies in the Digital Media and Technology Marketplace NEWPORT BEACH, Calif., April 18, 2018 -- Accelerize (OTCQB: ACLZ) (OTCBB:...
Apr 18, 2018 12:30 pm UTC| Business
BOTHELL, Wash., April 18, 2018 -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today announced that it will...
Apr 18, 2018 12:30 pm UTC| Business
PRINCETON, N.J., April 18, 2018 -- Origin, Inc., a Phase IIb clinical-stage biotechnology company, today announced that the US Food and Drug Administration has approved its request to conclude patient recruitment in the...